Cargando…

FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST trial. Diabetes 2012;61:3005–3011

Detalles Bibliográficos
Autores principales:	Zhang, X, Qi, Q, Zhang, C, Hu, FB, Sacks, FM, Qi, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Errata
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554380/ http://dx.doi.org/10.2337/db13-er02a

Ejemplares similares

B-Cell cross-presentation of autologous antigen precipitates diabetes. Diabetes 2012;61:2893–2905
por: Mariño, E, et al.
Publicado: (2013)

Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931
por: Subauste, AR, et al.
Publicado: (2013)

FTO Genotype and 2-Year Change in Body Composition and Fat Distribution in Response to Weight-Loss Diets: The POUNDS LOST Trial
por: Zhang, Xiaomin, et al.
Publicado: (2012)

Toward Precision Weight-Loss Dietary Interventions: Findings from the POUNDS Lost Trial
por: Qi, Lu, et al.
Publicado: (2023)

Gut-microbiome related LCT genotype and 2-year changes in body composition and fat distribution: the POUNDS Lost Trial
por: Heianza, Yoriko, et al.
Publicado: (2018)

What Is the Profiles for Predicting Treatment Responsiveness in Gastroesophageal Reflux Disease? (Gut 2012;61:501-506)
por: Park, Seon Young
Publicado: (2012)

PCSK7 Genotype Modifies Effect of a Weight-Loss Diet on 2-Year Changes of Insulin Resistance: The POUNDS LOST Trial
por: Huang, Tao, et al.
Publicado: (2015)

IRS1 Genotype Modulates Metabolic Syndrome Reversion in Response to 2-Year Weight-Loss Diet Intervention: The POUNDS LOST trial
por: Qi, Qibin, et al.
Publicado: (2013)

Erratum. Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes. Diabetes 2012;61:2134–2145
por: Wang, Zongwei, et al.
Publicado: (2021)

AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes 2012;61:3114–3125
por: Zhang, W, et al.
Publicado: (2013)

Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study
por: Liu, Gang, et al.
Publicado: (2020)

FRI074 Rise In Fasting Ghrelin Level In Response To Weight Loss Predicts Future Weight Regain In The POUNDS LOST Trial
por: Tong, Jenny, et al.
Publicado: (2023)

Blood DNA methylation at TXNIP and glycemic changes in response to weight-loss diet interventions: the POUNDS Lost Trial
por: Li, Xiang, et al.
Publicado: (2022)

Effect of diet composition and weight loss on resting energy expenditure in the POUNDS LOST study
por: de Jonge, Lilian, et al.
Publicado: (2012)

Genetic variation of fasting glucose and changes in glycemia in response to 2-year weight-loss diet intervention: the POUNDS Lost trial
por: Wang, Tiange, et al.
Publicado: (2016)

Genome Sequence of Fusarium graminearum Isolate CS3005
por: Gardiner, Donald M., et al.
Publicado: (2014)

Changes in Gut-Microbiota-Related Metabolites and Long-Term Improvements in Lipoprotein Subspecies in Overweight and Obese Adults: The POUNDS Lost Trial
por: Heianza, Yoriko, et al.
Publicado: (2021)

Increased Expression of Brain-derived Neurotrophic Factor in Irritable Bowel Syndrome and Its Correlation With Abdominal Pain (Gut 2012;61:685-694)
por: Joo, Young-Eun
Publicado: (2013)

Comment on: Visinoni et al. The Role of Liver Fructose-1,6-Bisphosphatase in Regulating Appetite and Adiposity. Diabetes 2012;61:1122–1132
por: Masotti, Andrea
Publicado: (2012)

Changes in Gut Microbiota–Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial
por: Heianza, Yoriko, et al.
Publicado: (2018)

Effect of Diet Composition on Energy Expenditure during Weight Loss: The POUNDS LOST Study
por: Bray, George A., et al.
Publicado: (2011)

Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
por: Brunetti, Antonio, et al.
Publicado: (2012)

Comment on: Vila et al. B-Type Natriuretic Peptide Modulates Ghrelin, Hunger, and Satiety in Healthy Men. Diabetes 2012;61:2592–2596
por: Jordan, Jens, et al.
Publicado: (2012)

Response to Comment on: Visinoni et al. The Role of Liver Fructose-1,6-Bisphosphatase in Regulating Appetite and Adiposity. Diabetes 2012;61:1122–1132
por: Fam, Barbara C., et al.
Publicado: (2012)

Basic and clinical immunology – 3011. Evaluation of selected parameters of cellular immunity at diagnosis in children with osteosarcoma
por: Markiewicz, Katarzyna, et al.
Publicado: (2013)

Comment on: Winkler et al. Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis. Diabetes 2012;61:513–523
por: Mahla, Ranjeet Singh
Publicado: (2012)

Response to Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
por: Froguel, Philippe, et al.
Publicado: (2012)

Response to Comment on: Vila et al. B-Type Natriuretic Peptide Modulates Ghrelin, Hunger, and Satiety in Healthy Men. Diabetes 2012;61:2592–2596
por: Vila, Greisa, et al.
Publicado: (2012)

Frequency of consuming foods predicts changes in cravings for those foods during weight loss: The POUNDS Lost Study
por: Apolzan, John W., et al.
Publicado: (2017)

Response to Comment on: Winkler et al. Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis. Diabetes 2012;61:513–523
por: Kintscher, Ulrich
Publicado: (2012)

Comment on: Greenbaum et al. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes. Diabetes 2012;61:1323–1330
por: Vialettes, Bernard, et al.
Publicado: (2012)

Comment on: Straznicky et al. Neuroadrenergic Dysfunction Along the Diabetes Continuum: A Comparative Study in Obese Metabolic Syndrome Subjects. Diabetes 2012;61:2506–2516
por: Frontoni, Simona
Publicado: (2013)

Effect of Dietary Composition of Weight Loss Diets on High Sensitivity C-Reactive Protein: The Randomized POUNDS LOST Trial
por: Nicklas, Jacinda M., et al.
Publicado: (2013)

Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Blood. 2012;120(23):4496-4504.
Publicado: (2013)

Erratum. Metformin Use in Prediabetes Among U.S. Adults, 2005–2012. Diabetes Care 2017;40:887–893
por: Tseng, Eva, et al.
Publicado: (2018)

Wiestner A. Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia. Blood. 2012;120(24):4684-4691.
Publicado: (2013)

Antimicrobial Susceptibility Patterns of Escherichia coli among Tunisian Outpatients with Community-Acquired Urinary Tract Infection (2012–2018): Erratum
Publicado: (2021)

Pretreatment Fasting Glucose and Insulin as Determinants of Weight Loss on Diets Varying in Macronutrients and Dietary Fibers—The POUNDS LOST Study
por: Hjorth, Mads F., et al.
Publicado: (2019)

Comment on: Schuit et al. β-Cell–Specific Gene Repression: A Mechanism to Protect Against Inappropriate or Maladjusted Insulin Secretion? Diabetes 2012;61:969–975
por: Rutter, Guy A., et al.
Publicado: (2012)

Response to Comment on: Greenbaum et al. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes. Diabetes 2012;61:1323–1330
por: Greenbaum, Carla J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jl42vv8c02ifebdt300n1167s9